04:50 PM EDT, 07/17/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on July 15, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $2,355,544. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 646,231 shares of the company, with 130 shares held directly and 646,101 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924019674/xslF345X03/form4-07172024_040701.xml

Price: 337.86, Change: +6.42, Percent Change: +1.94